Martin Meglasson is V-P & Discovery Research at LIGAND PHARMACEUTICALS INC (LGND). They have made 6 open-market trades across 2 companies since 2006, most recently 2015-05-20.
CIK 0001280564
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $183K since 2007, against 1 sale. Across 5 scored buys the stock is down 2.3% at ninety days, and 2.6 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -11.2% | -2.3% | -2.3% |
| Alpha | -5.4% | -2.6% | -2.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLPH | BUY | 2015-05-20 | 2015-05-22 | $8.40 | $6K | -13.1% | -0.7% | -0.7% |
| BLPH | BUY | 2015-02-19 | 2015-02-23 | $12.00 | $144K | -13.1% | -0.7% | -0.7% |
| LGND | BUY | 2010-05-11 | 2010-05-11 | $1.63 | $10K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2008-05-09 | 2008-05-09 | $3.36 | $10K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2007-08-30 | 2007-08-30 | $6.19 | $12K | -9.9% | -3.4% | -3.4% |
| LGND | SELL | 2006-12-15 | 2006-12-19 | $11.23 | $60K | -9.9% | -3.4% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.